A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

August 26, 2025

Study Completion Date

August 26, 2025

Conditions

Obesity

Interventions

DRUG

LY3437943

Administered SC

OTHER

Placebo

Administered SC

Trial Locations (3)

Columbia University Irving Medical Center, New York

AdventHealth Orlando, Orlando

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT06313528 - A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943 | Biotech Hunter | Biotech Hunter